We are live on ! Find out more
State of Wisconsin Investment Board

State of Wisconsin Investment Board Portfolio holdings

AUM $43.7B
1-Year Est. Return 27.76%
This Fund
S&P 500
This Quarter Est. Return
+6.85%
1 Year Est. Return
+27.76%
3 Year Est. Return
+95.56%
5 Year Est. Return
+123.77%
10 Year Est. Return
+486.44%
AUM
$36.4B
AUM Growth
+$2.59B
Cap. Flow
+$610M
Cap. Flow %
1.67%
Top 10 Hldgs %
16.21%
Holding
1,499
New
44
Increased
654
Reduced
471
Closed
52

Sector Composition

Rank Sector Weight
1 Financials 17.33%
2 Technology 16.38%
3 Healthcare 12.64%
4 Industrials 10.07%
5 Communication Services 10%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIGL icon
1351
Rigel Pharmaceuticals
RIGL
$782M
$330K ﹤0.01%
8,500
ATRA icon
1352
Atara Biotherapeutics
ATRA
$83.1M
$326K ﹤0.01%
720
KOS icon
1353
Kosmos Energy
KOS
$1.49B
$322K ﹤0.01%
47,060
EGRX
1354
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$321K ﹤0.01%
6,000
FHB icon
1355
First Hawaiian
FHB
$3.36B
$320K ﹤0.01%
10,954
+144
+1% +$4.22K
WVE icon
1356
Wave Life Sciences
WVE
$1.03B
$316K ﹤0.01%
+9,000
New +$262K
PGNX
1357
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$315K ﹤0.01%
53,000
IOVA icon
1358
Iovance Biotherapeutics
IOVA
$3.05B
$312K ﹤0.01%
39,000
LXRX icon
1359
Lexicon Pharmaceuticals
LXRX
$1.05B
$306K ﹤0.01%
31,000
ABEO icon
1360
Abeona Therapeutics
ABEO
$425M
$301K ﹤0.01%
760
MCY icon
1361
Mercury Insurance
MCY
$5.84B
$301K ﹤0.01%
5,625
+74
+1% +$4.07K
TAHO
1362
DELISTED
Tahoe Resources Inc
TAHO
$301K ﹤0.01%
62,805
CBI
1363
DELISTED
Chicago Bridge & Iron Nv
CBI
$300K ﹤0.01%
+18,583
New +$303K
CNA icon
1364
CNA Financial
CNA
$13.7B
$296K ﹤0.01%
5,574
+82
+1% +$4.32K
PRTK
1365
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$286K ﹤0.01%
16,000
KERX
1366
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$284K ﹤0.01%
61,000
BCRX icon
1367
BioCryst Pharmaceuticals
BCRX
$2.71B
$275K ﹤0.01%
56,000
MDGL icon
1368
Madrigal Pharmaceuticals
MDGL
$12.4B
$275K ﹤0.01%
+3,000
New +$171K
NVTA
1369
DELISTED
Invitae Corporation
NVTA
$263K ﹤0.01%
29,000
KPTI icon
1370
Karyopharm Therapeutics
KPTI
$46M
$250K ﹤0.01%
1,733
STML
1371
DELISTED
Stemline Therapeutics, Inc.
STML
$250K ﹤0.01%
16,000
NVAX icon
1372
Novavax
NVAX
$1.31B
$248K ﹤0.01%
10,000
TVRD
1373
Tvardi Therapeutics
TVRD
$22.1M
$245K ﹤0.01%
556
ACHN
1374
DELISTED
Achillion Pharmaceuticals
ACHN
$245K ﹤0.01%
85,000
CYTK icon
1375
Cytokinetics
CYTK
$10.5B
$244K ﹤0.01%
30,000

Similar funds

State of Wisconsin Investment Board's Q4 2017 Portfolio in Review

As of Q4 2017, State of Wisconsin Investment Board held 1,499 positions worth $36.4B, up 7.6% from $33.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

State of Wisconsin Investment Board's Q4 2017 filing shows 44 new, 654 increased, 471 reduced and 52 closed positions. Its largest new stake was Liberty Global Class C: 1,115,354 shares worth $37.7M. The largest sale was Alphabet (Google) Class A, an estimated $62.1M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

  • State of Wisconsin Investment Board's largest Q4 2017 buy was Liberty Global Class C: 1,115,354 shares worth $37.7M.
  • State of Wisconsin Investment Board added most to Discovery, Inc. Series C Common Stock in Q4 2017, an estimated $125M increase.
  • State of Wisconsin Investment Board's biggest Q4 2017 reduction was Alphabet (Google) Class A, cutting an estimated $62.1M.
  • State of Wisconsin Investment Board fully exited CR Bard Inc. in Q4 2017, selling an estimated $47.7M.
  • State of Wisconsin Investment Board's ten largest holdings make up 16% of its $36.4B portfolio in Q4 2017.
  • State of Wisconsin Investment Board opened 44 new positions and closed 52 in Q4 2017.
  • State of Wisconsin Investment Board's portfolio value rose 7.6% quarter-over-quarter to $36.4B.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2017, filed 8 Feb 2018.